Pharma news
Americas
IP law has yet to catch up with the technological capabilities of 3D printing, but by taking pre-emptive action, companies can maximise their IP protection under the current legal framework. Arlene Chow and Nitya Anand of Hogan Lovells report. 5 January 2017
Americas
Intellectual property law firm Fitzpatrick, Cella, Harper & Scinto has appointed Susanne Flanders, Natalie Lieber and Dennis McMahon as partners in the firm. 4 January 2017
Americas
Sanofi, and its subsidiary Genzyme, has targeted two pharmaceutical companies in patent lawsuits related to its drug Aubagio. 3 January 2017
Pharma
It appears necessary and perhaps inevitable that further guidance from the UK Court of Appeal will be provided on the issue of second medical use patents, following the high-profile dispute between Warner-Lambert and Actavis. Geoff Hussey and Christopher Burnett of AA Thornton & Co report. 3 January 2017
Asia-Pacific
A report released by the Australian government has said Australia's extension of term scheme for patents in the pharmaceutical industry "has had little effect" on investment and innovation. 23 December 2016
Pharma
Teva has filed a complaint against nine pharmaceutical companies including Dr Reddy's Laboratories, Sandoz and Mylan for alleged patent infringement over Copaxone, a treatment for patients with multiple sclerosis. 23 December 2016
Americas
Millennium Pharmaceuticals, now known as Takeda Oncology, has filed a complaint against US-based MSN Laboratories for patent infringement of Velcade, a treatment for cancer. 22 December 2016
Pharma
A combination of patents, SPCs and regulatory exclusivities should be considered carefully in order to maximise the exclusivity available for cell therapies, as Glyn Truscott of Elkington + Fife explains. 22 December 2016
Pharma
At the Life Sciences Patents Network Europe 2016, a conference hosted in London by LSIPR, Thomas Kolzau of Enin Pharma led a roundtable on mature licensing strategies. 20 December 2016
Americas
A Boston-based hospital, Brigham and Women’s Hospital, has been awarded $10.2 million in royalty payments after it won a patent case against pharmaceutical company Perrigo. 19 December 2016